NCT06513208 Ketorolac Effects on Post-operative Pain and Lumbar Fusion
| NCT ID | NCT06513208 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | University of Maryland St. Joseph Medical Center |
| Condition | Lumbar Spinal Fusion |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-01 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 140 participants in total. It began in 2026-01 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Eligibility Criteria
Inclusion Criteria: * 18-85 years old (inclusive) * Elective posterior lumbar instrumented fusion * One or two level fusion * Consent to participate in study and willing to adhere to study follow up * English proficiency Exclusion Criteria: * \< 18 or \> 85 years old * History of renal failure, dialysis, or creatinine over 1.50 mg/dl * Active or recent smoker (active within past 6 months) * Revision surgery * Auto/worker compensation * Active cancer or history of chemotherapy in past 6 months * Active narcotic use within 3 months of surgery date * Infection at operative levels * Any allergies to NSAIDs or Opioids
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06513208 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Lumbar Spinal Fusion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06513208 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06513208 currently recruiting?
Yes, NCT06513208 is actively recruiting participants. Contact the research team at ajanyavula@umm.edu for enrollment information.
Where is the NCT06513208 trial being conducted?
This trial is being conducted at Towson, United States.
Who is sponsoring the NCT06513208 clinical trial?
NCT06513208 is sponsored by University of Maryland St. Joseph Medical Center. The trial plans to enroll 140 participants.